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Abstract
Background: Influenza viruses attach to cells via sialic acid receptors. The viral neuraminidase
( N A )  i s  n e e d e d  t o  r e m o v e  s i a l i c  a c i d s  s o  that newly budded virions can disperse. Known
mechanisms of resistance to NA inhibitors include mutations in the inhibitor binding site, or
mutations in the hemagglutinin that reduce avidity for sialic acid and therefore reduce the
requirement for NA activity.
Results:  Influenza H3N2 isolates A/Oklahoma/323/03 (Fujian-like), A/Oklahoma/1992/05
(California-like), and A/Oklahoma/309/06 (Wisconsin-like) lost NA activity on passage in MDCK
cells due to internal deletions in the NA-coding RNA segment. The viruses grow efficiently in
MDCK cells despite diminished NA activity. The full length NA enzyme activity is sensitive to
oseltamivir but replication of A/Oklahoma/323/03 and A/Oklahoma/309/06 in MDCK cells was
resistant to this inhibitor, indicating that NA is not essential for replication. There was no change
in HA activity or sequence after the NA activity was lost but the three viruses show distinct, quite
restricted patterns of receptor specificity by Glycan Array analysis. Extensive predicted secondary
structure in RNA segment 6 that codes for NA suggests the deletions are generated by polymerase
skipping over base-paired stem regions. In general the NA deletions were not carried into
subsequent passages, and we were unable to plaque-purify virus with a deleted NA RNA segment.
Conclusion: H3N2 viruses from 2003 to the present have reduced requirement for NA when
passaged in MDCK cells and are resistant to NA inhibitors, possibly by a novel mechanism of
narrow receptor specificity such that virus particles do not self-aggregate. These viruses delete
internal regions of the NA RNA during passage and are resistant to oseltamivir. However, deletions
are independently generated at each passage, suggesting that virus with a full length NA RNA
segment initiates the first round of infection.
Background
Influenza viruses have two membrane bound surface glyc-
oproteins, hemagglutinin (HA) and neuraminidase (NA).
HA is involved in virus attachment to cell surface receptors
and mediates entry of the virus into the cell by a mem-
brane fusion process. NA is required for virus release. The
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enzyme catalyses cleavage of the α-ketosidic linkage
between a terminal sialic acid and an adjacent sugar resi-
due. The removal of sialic acid from the carbohydrate
moiety of newly synthesized hemagglutinin and neurami-
nidase is necessary to prevent aggregation of the virions at
the cell surface [1,2]. This receptor-destroying role
assumes similar specificity of HA and NA, and there are
several reports describing reciprocal changes in HA affin-
ity and NA activity [3-5]. However, the specificities of HA
and NA are not always matched [2,6,7]. We previously
showed that a Fujian-like virus, A/Oklahoma/323/03,
does not elute from red blood cells by its own NA activity
or even with Vibrio cholerae sialidase [8], indicating that
NA activity does not cleave the receptor bound by the HA.
Efficient growth of A/OK/323/03 in tissue culture sug-
gested that either the non-cleavable receptor of red blood
cells is not present, or the virus is not dependent on recep-
tor destroying activity. We have now shown that A/Okla-
homa/323/03 and several subsequent isolates accumulate
large internal deletions of the neuraminidase coding
sequence. The resulting loss in NA activity has no detri-
mental effect of growth of the viruses in MDCK cells.
Results
We used four H3N2 influenza viruses that were isolated in
primary rhesus monkey kidney (RMK) cells from throat
swabs in the winters of 2003, 2005, 2006 and 2008. All
the isolates grew to high yield (HA titer = 16–64) in the
first passage when transferred to Madin-Darby canine kid-
ney (MDCK) cells. The HA and NA sequences showed that
A/Oklahoma/323/03 is similar to the A/Fujian/411/02
vaccine strain [8] while A/Oklahoma/1992/05, A/Okla-
homa/309/06 and A/Oklahoma/483/08 are closely
related to H3N2 vaccine strains A/California/7/04, A/Wis-
consin/67/05 and A/Brisbane/10/07 respectively.
NA activity of A/OK/323/03 decreased on passage
A/OK/323/03 grows robustly in MDCK cells (106–107
TCIU per 105 cells) but several times we noticed a loss in
NA activity as the virus was passaged. We ran a PCR reac-
tion of RNA segment 6 using NA specific primers comple-
mentary to the non coding region at the 3' and 5' ends and
found that the PCR product from a virus stock that had
lost NA activity was about half the size of the full-length
NA gene segment (Figure 1). To determine when the dele-
tions occurred, we passaged the original virus stock from
RMK cells in MDCK cells, as 10-fold serial dilutions in 6-
well plates, under two different conditions of infection.
One was limiting dilution, using 1 μl of the last well that
showed infection to infect the first well of the next passage
each time. In the other condition, we used 1 μl of the first
well of the dilution series to infect the first well of the next
passage (an average of 1000 TCIU per 105 cells, moi 0.01).
We measured HA and NA activities and the infectious
virus yield (TCIU) at each passage, P1 to P12. There was no
significant decrease in the HA activity or in the titer of
Deletion of the NA coding RNA segment of A/OK/323/03 Figure 1
Deletion of the NA coding RNA segment of A/OK/323/03. NA-specific RT-PCR products of H3N2 virus stocks from 
MDCK cells separated on a 1% agarose gel stained with ethidium bromide. Lane1,1 kb ladder; Lanes 2–6 are duplicate loadings 
of RT-PCR products from three different stocks of A/OK/323/03; Lane 7–9 are two different 2005 isolates. The full-length NA 
RNA segment is 1467 nucleotides.Virology Journal 2009, 6:22 http://www.virologyj.com/content/6/1/22
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released virus during the passages under either condition
but, starting from P3, the NA activity was reduced under
the higher multiplicity conditions and did not recover
even when the virus was passaged under limiting dilution
following the high multiplicity passages (Figure 2). Under
limiting dilution conditions there was little decrease in
NA activity, as measured by NA/HA ratio. There was no
significant difference in virus growth under the two condi-
tions; for passages 3 through 12, the average HA log2 titer
was 5.7 ± 1.1 under limiting dilution and 5.3 ± 1.1 at the
higher multiplicity of infection (moi), while the average
log(TCIU) was 5.9 ± 0.5 under limiting dilution and 5.6 ±
0.7 at the higher moi.
We passaged A/Oklahoma/1992/05 five times under the
same conditions and found ~50% decrease in NA activity
but no change in HA titer or in the titer of released virus
during the passages. With this virus, the decrease in NA
activity occurred under both limiting dilution and moi
0.01 conditions.
Deletions in the NA gene
We carried out reverse transcriptase PCR (RT-PCR) on the
medium from each passage of A/OK/323/03 using NA
specific primers designed from the 3' and 5' ends of the
NA gene segments. The size and sequence of the PCR
product from limiting dilution passages was the 1467
nucleotides expected for full-length NA, with no muta-
tions compared to the parental virus. However, with
higher multiplicity infection the NA gene segment gave
short PCR products (Figure 3A). In most passages there
was still a trace of full-length NA PCR product and so after
P10 we passaged the higher multiplicity virus stock twice at
limiting dilution (H10+1L, H10+2L) to see if the virus
reverted back to its original NA length and activity. There
was no significant increase in NA activity (Figure 2)
despite a higher proportion of PCR product at the full-
length position on the gel. After both limiting dilution
passages there was a prominent PCR product at ~300 bp
(Figure 3B). We passaged A/OK/1992/05 under the same
conditions of limiting dilution and 0.01 moi and again
saw short PCR products, but, in accord with the results for
NA activity, there was no consistent difference between
limiting dilution and higher multiplicity passages (Figure
3C).
Sequences of bands cut from the gels from P2 to P12 of A/
OK/323/03 showed internal deletions from the normal
length of 1467 nucleotides down to ~300 bp (Figure 4).
We sequenced short PCR bands that appeared to be well
separated at each passage. As expected, some gel bands
contained mixed sequences that were uninterpretable.
However, all the PCR products that yielded clear sequence
represented NA-specific RNA fragments, each resulting
NA activity of A/OK/323/03 was reduced during passage at moi 0.01 but not at limiting dilution Figure 2
NA activity of A/OK/323/03 was reduced during passage at moi 0.01 but not at limiting dilution. The virus yield at 
each passage (TCIU) is compared to NA activity expressed as NA/HA ratio during limiting dilution passages (left) or moi 0.01 
passages (right). Measurements were made on the first well for 0.01 moi passages and on the last well that showed infection 
for the limiting dilution passages. For comparison at the same scale, we plotted the ratio NA/(log2HA) and log(TCIU).Virology Journal 2009, 6:22 http://www.virologyj.com/content/6/1/22
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from a single internal deletion within the NA gene. Both
ends of the NA RNA were retained in all the deleted NA
products, with 82 nucleotides or more at the 5' end and
158 or more nucleotides at the 3' end. We saw no carryo-
ver of deleted products from one passage to the next; even
when PCR products appeared the same size, the sequences
showed different junctions in each passage (Figure 4).
However, when the high multiplicity P10 was passaged
twice at limiting dilution, a fragment with a deletion of
1126 nucleotides (82/1209) was retained through both
limiting dilution passages (Table 1).
Deleted NA genes were obtained from A/Oklahoma/
1992/05 starting in the second passage in MDCK cells
under either limiting dilution or 0.01 moi; there was more
full length NA under limiting dilution conditions but not
the dramatic difference compared to higher moi seen with
A/OK/323/03. At limiting dilution, a deleted PCR product
of A/OK/1992/05 NA at P3 had the identical 1097 nucle-
otide deletion to one at P2 (junction 145/1244; Table 1).
A/Oklahoma/309/06 and A/Oklahoma/483/08 showed
short NA-specific PCR products even at P1 in MDCK cells
(Table 1). In contrast to the single internal deletions seen
so far, A/Oklahoma/309/06 yielded mosaic structures
containing multiple junctions and repeated sequences.
Some were mixtures in which the junctions were unclear,
but one sequence was unambiguous (Table 2). We inves-
tigated another Wisconsin-like virus, A/OK/1472/06 and
found a similar mosaic structure in a deleted NA RNA
(Table 2). To determine if these were indeed from single
RNAs we cloned A/Oklahoma/309/06 P1 PCR products
into pBluescript. The resulting clones showed the same
mosaic sequences as found in the direct sequencing of
PCR products.
We plaque purified viruses from several stocks containing
deleted NA gene segments but were unable to isolate any
virus that lacked a full length NA RNA.
We attempted to follow the generation of the deletions by
real-time PCR with SYBR green detection using primer sets
that amplified (a) the conserved 3' and 5' end sequences
or (b) the middle portion that was deleted. We hoped to
see an increase in "a" product as the ends came closer
together and a decrease in "b" product as the NA became
deleted, either during a single cycle experiment or over
multiple cycles, but there was no significant change in the
ratios at 6 hr, 18 hr or 72 hr. A better experiment would
have used a primer set within the retained 5' or 3' regions
rather than spanning the whole segment, but no suitable
primers were identified by the ABI software, probably
because of the high A (or U) content (33.4%) of influenza
mRNA (or vRNA) strands.
A/OK/323/03 and A/Oklahoma/309/06 are sensitive to 
Tamiflu in the enzymatic assay but resistant in MDCK 
culture
The high level of NA deletions suggests that little or no NA
activity is required for multicycle replication of A/OK/
323/03 in MDCK cells. We tested this by growing viruses
in the presence of oseltamivir. In our standard fluores-
cence NA assay, oseltamivir carboxylate inhibited NA
activity of A/OK/323/03 with an IC50 of 8 nM and A/OK/
309/06 inhibition was similar (IC50 6 nM). We inoculated
MDCK cells with serial dilutions of A/OK/323/03 that had
been grown under strictly limiting dilution conditions
and so had full-length NA gene segment and high NA
activity, and grew the virus for one passage in the presence
and absence of oseltamivir carboxylate (a kind gift from
Dr. Warren Kati, Abbott). Ten fold dilutions of oseltamivir
starting at 10 μM were added to the infection medium
immediately after virus adsorption, the plates incubated
at 37°C for 3 days, and virus yield measured by HA titra-
tion. The results are shown in Figure 5. Replication of a
control virus, NWS-Memphis/31/98, was inhibited by 1
μM oseltamivir, with barely detectable HA titer and little
cytopathic effect (cpe) in the cultures. A/OK/03 replica-
tion was not inhibited up to 10 μM oseltamivir with little
change in virus yield and high cpe. A/OK/309/06 consist-
ently showed higher virus yield as oseltamivir concentra-
tion was increased from 1 nM to 1 μM (Figure 5).
We passaged A/Oklahoma/323/03 and A/Oklahoma/
309/06 three times in the presence of 10 μM oseltamivir.
RT-PCR of viral RNA from the last passage showed no
trace of the full length NA band and very weak shorter
products (Figure 5B). We sequenced some short bands
from each virus and found multiple junctions in A/Okla-
homa/309/06 similar to those seen after passage without
oseltamivir (Table 2). A/Oklahoma/323/03 contained a
long internal deletion (192–1209) but also showed two
other small deletions (1288–1300 and 1412–1418, Table
2).
Deletions are not randomly occurring in other gene 
segments
The PCR products shown in Figure 3 were obtained using
NA-specific primers, and all the sequences we obtained of
subgenomic PCR products were derived from the NA gene
segment. Growth of influenza at high multiplicity is
known to generate defective (DI) particles containing
internally deleted fragments of RNA segments, particu-
larly from the polymerase genes. Therefore it was possible
that the deletions we found in NA merely reflected
increasing proportions of randomly generated DI viruses.
To investigate if the deletions were occurring in all RNA
segments we amplified RNA from selected passages by RT-
PCR using common primers that will amplify all 8 seg-
ments of influenza virus. There were several small bandsVirology Journal 2009, 6:22 http://www.virologyj.com/content/6/1/22
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Deletions in NA RNA as viruses were passaged at limiting dilution or at moi of 0.01 Figure 3
Deletions in NA RNA as viruses were passaged at limiting dilution or at moi of 0.01. RT-PCR products of NA 
genes from different passages amplified from viral cDNA were separated on a 1% agarose gel and stained with ethidium bro-
mide. A and B: A/OK/323/03. A. Lane1, 1 kb ladder; lanes 2–6 are P1-P5; H = higher multiplicity (moi = 0.01) passages; L = lim-
iting dilution passages. Limiting dilution passages retained the full length NA band, but passages at higher moi had little full 
length band and showed faster migrating bands resulting from internal deletions of the NA RNA segment. B. PCR products 
after further passages. 10H+1L is 10 passages at 0.01 moi followed by one passage at limiting dilution; 11L is limiting dilution 
passage 11; 10H+2L is 10 passages at high moi followed by two at limiting dilution; 12L is limiting dilution passage 12. C. A/OK/
1992/05. Lanes are the same as panel A with the addition of negative (no RNA) and positive controls. Deletions are seen at P2 
and higher but there is only minor decrease in full length NA at the higher multiplicity compared to limiting dilution.Virology Journal 2009, 6:22 http://www.virologyj.com/content/6/1/22
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obtained from the universal primers in addition to those
amplified by NA-specific primers but sequences obtained
indicated that most were the result of mis-priming. We
found only one internal deletion from another gene,
which was an internal deletion of 1394 nucleotides from
segment 5 RNA, coding for the NP. We conclude that there
were few deletions occurring in the other gene segments
and that the NA was specifically lost when A/OK/323/03
was passaged at an moi of ~0.01.
Properties and sequence of the HA did not change when 
NA gene was deleted
The NA-deficient virus stock of A/OK/323/03 shown in
Figure 1 yielded no visible full-length NA PCR product
and has only background NA activity. To see if the loss of
Table 1: Single internal deletions in the NA genes of H3N2 viruses isolated from 2003 to 2008.
Virus Passage No.1 First block
1 to ...
Second block
... to 1467
Length of fragment
Fujian-like virus
OK/323/03 P7Ld1 181 1194 454
P10H+1Ld1 82 1209
P10H+2Ld1 82 1209 341
P13Ld1 261 1181 547
P14Hd1 73 1207 333
California-like virus
OK/1992/05 P2Hd1 51 1148 370
P2Ld1 145 1244 368
P3Ld1 145 1244 368
P3Hd1 1252 1301 320
Wisconsin-like viruses
OK/1472/06 P1d2 221 1166 522
OK/51/06 P1d1 40 1244 263
Brisbane-like viruses
OK/5545/07 P1d1 231 1308 390
OK/1806/08 P1d1 145 1210 402
OK/483/08 P1d1 145 1261 351
1PCR products are numbered from larger to smaller. P2Hd1 is the larger deleted product seen at passage 2 (P2) under higher (H) moi. P7Ld1 was 
from the 7th passage under limiting dilution (L).
2 29 nucleotides in between are unidentifiedVirology Journal 2009, 6:22 http://www.virologyj.com/content/6/1/22
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Subgenomic NA segments showed different internal deletions but all retained the 5' and 3' ends Figure 4
Subgenomic NA segments showed different internal deletions but all retained the 5' and 3' ends. A. Sequence 
chromatograms showing the junctions in some deleted NA segments of A/OK/323/03. The numbers indicate the junction 
nucleotides. B. Schematic showing examples of deletions of the NA coding region of A/OK/323/03. In all sequences, the 5' and 
3' ends are retained. Lines represent internal deletions and the number of nucleotides deleted is indicated. The junction nucle-
otides are noted in each case. Two unrelated deletions are shown for Passage 6. Other sequences were derived from NA but 
the junctions were unclear due to mixed products in the gel bands.Virology Journal 2009, 6:22 http://www.virologyj.com/content/6/1/22
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requirement for NA activity was accompanied by a change
in HA, we sequenced the HA segment in virus stocks that
showed no full length NA segment. There were no
changes in the HA sequences when compared to HA of
viruses passaged at low multiplicity.
HAs of 2003–2008 H3N2 viruses have different receptor 
specificities
One mechanism of resistance to NA inhibitors is by muta-
tions in the HA that lower avidity for receptors, thus
allowing the virus to shake itself off receptors without the
need for NA activity. There was no change in the HA
sequence as the viruses were passaged, even when the full
length NA gene became lost after multiple passages of A/
OK/323/03. However, we wondered if there were intrinsic
differences in HA binding in those viruses that are suscep-
tible to loss of NA when grown in MDCK cells. We previ-
ously showed that there were only quantitative differences
in binding specificity when viruses from 2003 and 2005
were assayed on the Glycan Array of the Consortium for
Functional Glycomics, even though the viruses showed
varying ability to agglutinate chicken red cells and one
virus had been adapted to grow in embryonated chicken
eggs [9]. We labeled purified viruses with Alexa 488 under
conditions that did not alter hemagglutination titers and
tested binding to current versions of the Glycan Array (Fig-
ure 6). The Wisconsin-like virus A/OK/309/06 binds more
glycans than the Fujian/02 and California/04 groups of
viruses. In addition to the minimal motif bound by those
viruses [9], A/OK/309/06 bound to a trisaccharide con-
taining 9-O-acetyl-N-acetyl neuraminic acid, and also to
any glycan with sialic acid linked α2–6 to N-acetylgalac-
tosamine, including when this disaccharide forms an
internal branch. In marked contrast, the Brisbane-like iso-
late A/OK/483/08 bound only when the sialic acid was
linked 2–6 to an extended polylactosamine. There was no
change in this pattern when different concentrations of
virus were tested or when re-tested a month later with a
different preparation of Alexa-labeled virus. Another Bris-
bane-like H3N2 isolate, A/OK/1123/08, showed the same
restricted binding specificity. The minimal units bound by
these viruses are shown in Table 3. As a control for the
binding experiment, an H1N1 isolate from 2008 bound
to essentially every 2–6 sialylated glycan on the array,
which by then contained 406 glycans (Figure 6).
Secondary structures in NA gene segments
To investigate if the secondary structure of RNA plays a
role in generating internal deletions, we examined possi-
ble secondary folding of the NA gene (RNA segment 6) of
the Oklahoma viruses using the program mFold version
3.2 [10,11]. We ran the program with both negative sense
viral RNA (vRNA) and the positive sense full length RNA
(cRNA) strands of A/OK/323/03, A/OK/1992/05 and A/
OK/309/06, using default RNA parameters or with varied
parameters. All the NA genes showed extensive secondary
structures with only slight variations as the parameters
were changed. Notably, all lower energy structures
brought the 5' and 3' ends into close proximity. The most
probable structures in the mFold output using default
parameters are shown in Figure 7, with the positions of
junctions in the deleted segments color coded (e.g. red is
joined to red). In some cases, the nucleotides that form
the junction when the segment is deleted are juxtaposed
in the predicted secondary structure (187/1041 in A/OK/
323/03, 125/1301 in A/OK/1992/05, 204/1253 in A/OK/
309/06). In other cases, folding stem-containing arms
into a tertiary structure would bring groups of junctions
together (e.g. 93–103 to 1194–1208 in A/OK/323/03, 51,
134, 145 to 1148, 1216, 1244 in A/OK/1992/05). Note
that in some cases there are ambiguities in assigning junc-
tions due to repeated nucleotides; for example, the junc-
tion listed as 80/1289 in Table 2 is actually somewhere in
the range 77/1286 to 81/1290. In other cases the ambigu-
Table 2: Mosaic fragments of the NA gene
Virus 5' end cRNA Joined to Joined to Joined to Joined to
After 1 passage in MDCK cells
A/OK/1472/06 1 – 63 1 – 81 1290 – 1467
A/OK/309/06 1 – 108 194 – 324 120 – 190 1227 – 1467
After 3 passages in the presence of oseltamivir
A/OK/323/03 1 – 191 1210 – 1287 1301 – 1411 1419 – 1467
A/OK/309/06 1 – 70 1 – 74 130 – 204 1253 – 1290 1310 – 1447Virology Journal 2009, 6:22 http://www.virologyj.com/content/6/1/22
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A. A/OK/323/03 and A/OK/309/06 can grow in the presence of oseltamivir Figure 5
A. A/OK/323/03 and A/OK/309/06 can grow in the presence of oseltamivir. The results shown are the virus yield, 
expressed as HA titer, for the average of two different virus doses grown in increasing concentrations of oseltamivir carboxy-
late. NWS-Mem/98 (H1N9) is included as a control virus that is sensitive to oseltamivir inhibition. B. PCR products of NA gene 
after growth of A/OK/323/03 and A/OK/309/06 in oseltamivir. No full-length NA gene segment was visible but small fragments 
appear as diffuse bands less than 500 bp in length.Virology Journal 2009, 6:22 http://www.virologyj.com/content/6/1/22
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ity is 1–2 nucleotides but in many junctions there is no
overlap so the assignment is precise. While the details are
slightly different when the negative sense vRNAs are
folded, in all cases we observed a predominance of junc-
tions in loops or close to the ends of hairpins. These
results suggest that deletions occur by polymerase skip-
ping across the ends of hairpins in secondary and tertiary
structure and they could originate on either positive or
negative sense RNA.
Discussion
During influenza infection, viruses that lack NA activity
usually fail to spread to new cells because they aggregate
at the infected cell surface due to binding of the HA to
sialic acid on the surface glycoproteins of neighboring
virus particles [1,2]. We previously isolated a mutant of
NWS-G70c (H1N9) virus that lacked NA activity due to a
large internal deletion in the NA gene, but this virus was
selected by adding bacterial sialidase to the growth
medium and was dependent on exogenous sialidase for
multicycle growth [12]. The low-NA H3N2 viruses
reported here do not require added sialidase for efficient
growth in MDCK cells. The viruses isolated in 2003, 2005
and 2006 have different susceptibilities to deletions in the
NA segment. A/OK/323/03 retained full NA segment
length and full NA activity when passaged strictly under
limiting dilution conditions (moi ~10-5), but generated
internal deletions of the NA gene when passaged at higher
moi of 0.01, with different deletions at each passage. A/
OK/1992/05 generated deleted NA segments that
increased with passage number, but there was only slight
difference if the passages were made at limiting dilution
or at 0.01 moi. A/OK/309/06 and A/OK/483/08 showed
deletions even after a single passage in MDCK cells. The 5'
and 3' ends were always retained, in accord with these
being the location of specific packaging signals [13,14].
We were unable to plaque-purify viruses with deleted NA
gene; there was always full length NA present. This sug-
gested there was some advantage of either full length NA
gene or NA activity. All these viruses were resistant to osel-
tamivir in replication assays but the NA was sensitive in
the enzyme assay, suggesting NA activity is not required
and therefore the requirement might be for the full-length
NA-coding RNA segment.
The deletions are targeted to the NA gene segment
The PCR reactions in Figures 1 and 3 were carried out with
NA-specific primers, so there was a possibility that the
deletions we saw in NA were just a subset of general
genome-wide deletions. It is well known that high-multi-
plicity passage of influenza virus leads to accumulation of
defective-interfering (DI) particles containing sub-
genomic RNAs resulting from internal deletions, most
commonly in the polymerase gene segments [15-19]. We
looked for subgenomic RNAs derived from other gene seg-
ments by using PCR primers with the common 3' and 5'
gene segment sequences. We found one non-NA subge-
nomic RNA with an internal deletion in the NP RNA seg-
ment. Other sub-genomic bands resulted from mis-
priming, presumably due to the short sequences (12 nt
and 13 nt) used to start the amplification. We conclude
that the large number of NA deletions we found result
from lack of selective pressure to retain NA when these
viruses replicate in MDCK cells.
Do H3N2 viruses delete NA because they have low 
receptor affinity or narrow specificity?
The 2003–2008 viruses used for these experiments all
agglutinate human red blood cells with a similar avidity,
giving titers of 16–64 when grown in MDCK cells. The
specific HA titers of purified virus preparations were not
significantly different (3–4 log2HAU per μg viral protein).
However, glycan array analysis showed different specifici-
ties. A/OK/309/06 had the broadest specificity, followed
by the 2003–5 viruses, while A/OK/483/08 was restricted
in its binding to sialylated polylactosamines of at least 5
Table 3: Minimal oligosaccharides bound by recent H3N2 viruses
Virus Minimal binding motifs
A/OK/323/03 (Fujian-like)1 Neu5Acα2–6Galβ1–4GlcNAc
Neu5Acα2–6GalNAcβ1–4GlcNAc
A/OK/1992/05 (California-like)1 Neu5Acα2–6Galβ1–4GlcNAc
Neu5Acα2–6GalNAcβ1–4GlcNAc
A/OK/309/06 (Wisconsin-like) Neu5Acα2–6Galβ1–4GlcNAc
Neu5Acα2–6GalNAcβ1–4GlcNAc
9OAcNeu5Acα2–6Galβ1–4GlcNAc
Neu5Acα2–6GalNAc in any context
A/OK/483/08 (Brisbane-like) Neu5Acα2–6Galβ1–4GlcNAcβ1–3Galβ1–4GlcNAc
1Data previously reported [9]Virology Journal 2009, 6:22 http://www.virologyj.com/content/6/1/22
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sugars (Figure 6 and Table 3). There was no correlation
between the variety of glycans bound and the ease of gen-
erating deletions in NA. The signal strength is similar
when similar amounts of virus are applied to the array. If
the diversity of glycans on the surface of an MDCK cell is
similar to that on the array we might expect that affinity,
and NA dependence, would correlate with diversity of
binding, but there is little information on the glycans
present on MDCK cells. The greatest loss in NA was seen
in A/OK/323/03, which is intermediate in binding specif-
icity. The HA sequence did not change in viruses as they
deleted the NA segment.
NA is not always a receptor-destroying enzyme
If the only function of NA is to cleave receptors bound by
the HA, then HA and NA activity of a viable virus should
be matched quantitatively (Kd of HA and Kcat of NA) and
qualitatively (same specificity). Several studies have
found that lower NA activity can be compensated by low
HA avidity [4-7,20,21] leading to conclusions that the
activities are balanced. However, these studies did not
consider specificity of binding and release. Many recent
H3N2 viruses do not elute from red cells by their NA activ-
ity, showing that the specificities of HA and NA are mis-
matched [8]. The NA activity of A/OK/323/03 can cleave
α2–6-linked sialic acid from the trisaccharide sialyllactose
but does not release the virus from red cells, indicating
that the HA binds to high affinity ligands that have a struc-
ture that is resistant to viral NA activity but sensitive to
sialidase from M. viridifaciens [8]. The hemagglutinating
site on N9 NA shows similar resistance to cleavage by viral
NA activity [22].
Glycan Array results for A/OK/309/06 and A/OK/483/08 Figure 6
Glycan Array results for A/OK/309/06 and A/OK/483/08. A/OK/309/06 (top panel) was run on CFG Printed Array ver-
sion 3.0 (320 glycans) while the others are v3.2 (406 glycans). For comparison, results are also shown for an H1N1 2008 isolate 
that binds to nearly every α2–6 sialylated glycan on the array (bottom panel). The array keys and data are available on the CFG 
web site [32]. The results are summarized in Table 3.Virology Journal 2009, 6:22 http://www.virologyj.com/content/6/1/22
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Oseltamivir inhibits the NA activity of A/OK/323/03 and
A/OK/309/06 but does not inhibit virus growth in MDCK
cells (Figure 5). Mechanisms that allow virus propagation
in the presence of NA inhibitors include mutations in the
drug binding site of NA, as in the resistance of recent
H1N1 human isolates that carry the H274Y mutation, but
in the 2003–2008 viruses studied here the NA enzyme
activity is fully sensitive to oseltamivir inhibition. A/OK/
309/06 was resistant to oseltamivir after a single passage
in MDCK cells, suggesting the potential exists for resist-
ance in humans by a mechanism in which NA activity is
not required. It has been noted that aggregation of virus
particles seen in electron micrographs when influenza
virus is grown without NA activity is due to virus-virus
interactions rather than the virus-cell interactions [1,2]
and it seems likely that it is more important for NA to
cleave sialic acids from the viral glycoproteins (only N-
linked glycans) than from the cell surface (N-linked and
O-linked glycans and glycolipids). Thus the specificities of
HA and NA do not need to be matched and, furthermore,
NA is not required if the HA does not bind to sialic acid
structures on other HAs. NAs of human viruses have a
marked preference for α2–3 linked sialic acid, in contrast
to the strict requirement of HA for α2–6 sialylated gly-
cans.
We previously showed that a reassortant H1N9 virus,
NWS-G70c, progressively lost NA coding capacity when
passaged in the presence of bacterial sialidase and anti-NA
antiserum [2,12,23]. The result was a group of viruses that
had no full-length NA segment and therefore no coding
capacity for the active NA enzyme. Each virus had a single
internal deletion in the NA gene with retention of at least
100 nucleotides at the 3' end of the genomic RNA and 200
nucleotides at the 5' end [23]. These viruses were depend-
ent on added sialidase for multi-cycle replication and we
did not succeed in adapting them to grow without exoge-
nous sialidase. Kawaoka and colleagues replicated these
NWS-G70c NA deletions by passaging the virus in MDCK
cells that constitutively expressed N2 NA. The resulting
NA-deficient virus was gradually weaned off its sialidase
requirement and eventually variants were obtained that
Potential secondary structures in RNA segment 6 for A/OK/323/03 (left), A/OK/1992/05 (center) and A/OK/309/06 (right) Figure 7
Potential secondary structures in RNA segment 6 for A/OK/323/03 (left), A/OK/1992/05 (center) and A/OK/
309/06 (right). Results shown are for the positive (sense) strand and were generated by the mFold RNA folding program 
[10,11]. The lowest energy foldings are shown. All are the positive strand; A/OK/1992/05 and A/OK/309/06 were obtained 
using default parameters in mFold, while A/OK/323/03 was obtained using the adjusted parameters listed in the Methods. 
Nucleotides at junctions in the deleted segments are shown, color coded by nucleotides that come together when the internal 
section is deleted.Virology Journal 2009, 6:22 http://www.virologyj.com/content/6/1/22
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could grow without added sialidase in MDCK cells, eggs
or mice. These viruses had low or zero ability to aggluti-
nate chicken red cells and they had multiple mutations in
the HA gene [6]. The authors concluded that adaptation to
grow without NA activity required a reduction in receptor
binding as occurs in NA inhibitor-resistant mutants that
can be released from their receptors by thermal motion
and so are not dependent on NA activity [24-27].
Deletions in NA but with no change in HA were reported
by Hughes et al. [7] when an H3N2 virus, A/Tottori/872/
94, was passaged in MDCK cells that had reduced surface
sialic acid. The authors concluded that the lower density
of sialic acids on the cell surface and on the viral glycopro-
teins resulted in lower avidity, thus allowing virus spread
in the absence of NA activity. However, the infectivity was
reduced by several orders of magnitude.
The NA-deficient stocks of A/OK/323/03 reported here
have very different properties. They were generated by pas-
saging virus in normal MDCK cells without any exoge-
nous sialidase. There was no decrease in infectious titer
during these passages and no change in HA activity. Ferra-
ris et al. [28] also reported H3N2 isolates from 2002 to
2005 that had no detectable NA activity. The 2003–2004
isolates that were further studied were resistant to NA
inhibitors and yielded no full-length NA PCR product.
The properties that we have described may be common
among recent H3N2 viruses. The concern is that these
viruses can replicate in the absence (or near absence) of
NA activity, and so are resistant to oseltamivir (Figure 5).
The OK/323/03 virus only acquired this trait after several
passages in MDCK cells, but the other viruses were resist-
ant after a single passage.
What is the selection for full length NA RNA?
The full-length NA gene segment of A/OK/323/03 was
never completely lost and we were unable to plaque-
purify a virus with no full-length NA segment. This is in
accord with the observation that different deletions were
found at each passage (Figure 4), suggesting the deletions
were generated anew during each passage.
It is important to note that the two conditions of passage
used for A/OK/323/03 were not strikingly different. While
one was strictly limiting dilution, the "high-multiplicity"
passages were inoculated with an moi of about 0.01. We
saw no accumulation of deleted polymerase gene frag-
ments, as are routinely found in infections when the moi
is >1 [18,19]. Cairns and Fazakas noted many years ago
that if cells are infected at high multiplicity, the virus yield
is much lower than if the infection is initiated with one
infectious particle, despite the fact that the final cycle of a
multi-cycle replication from a single infectious unit occurs
at high multiplicity [29]. They also pointed out that the
total yield of virus at the end of a multi-cycle replication
has an upper limit that is determined by the number of
cells, not by the number of infectious particles that initi-
ated the infection, except when the infection is poor due
to a high moi. We found that the virus yield, whether
measured as infectious units (TCIU) or as particles (HA
titration), is the same from 12 passages under 0.01-moi
conditions (1000 TCIU per well) as from limiting dilution
(~3 TCIU). Therefore replication is not impaired by the
higher moi or by the loss of NA activity. Our results could
be interpreted either as a positive selection for shorter NA
segments, with little or no requirement for NA activity, or
as negative selection against NA activity but a requirement
for at least the 3' and 5' NA RNA sequences. The total yield
of virus per well (105 cells) was 2–3 × 106 TCIUs, so if NA
deletions occur at a frequency of 10-4 or 10-5, positive or
negative selection may occur during higher multiplicity
multi-cycle infections but would not be observed at limit-
ing dilution.
Conclusion
The mechanism of deletion of internal segments of NA
requires two parts; a loss of selective pressure to retain NA
activity, and a mechanism to generate the deletions. Win-
ter et al proposed that influenza polymerase can generate
deletions by jumping across the ends of hairpins and even
to other templates [17,30] and the secondary structure
plots generated by mFold (Figure 7) support this idea for
the NA deletions, with tertiary structures also involved.
The loss of NA, and the ability of the human H3N2 viruses
to grow in the presence of an NA inhibitor, is not accom-
panied by changes in HA and appears to be a new mecha-
nism of resistance to NA inhibitors; lack of requirement
for NA activity as a consequence of a lack of binding of HA
to sialylated glycans on the viral glycoproteins.
It seems likely that the retention of at least a trace full-
length NA RNA segment in our experiments is due to its
benefits in packaging rather than the low amount of NA
activity that would be provided. The results may be best
explained if virus that has packaged eight full-length RNAs
is preferentially infectious but undergoes deletion during
replication because NA activity is not required.
Methods
Viruses and cells
The viruses used in this study were A/Oklahoma/323/03,
a Fujian-like isolate (H3N2), [8], A/Oklahoma/1992/05,
a California-like H3N2 isolate, A/Oklahoma/309/06, a
Wisconsin-like H3N2 isolate and A/NWS/33(P227H)HA –
A/Memphis/31/98NA  (NWS-Mem/31/98, H1N2, [23]).
Viruses were grown in Madin-Darby canine kidney
(MDCK) cells in DMEM:Ham's F12 medium (1:1) withVirology Journal 2009, 6:22 http://www.virologyj.com/content/6/1/22
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ITS+ (BD Biosciences) and trypsin added as previously
described [12]. For RNA extraction, the virus-containing
medium was cleared of cell debris (3,000 g for 5 min)
then virus was concentrated by sedimentation (SW28
rotor, 25,000 rpm for 2 hr at 4°). The virus pellet was
resuspended in CaMg-saline (0.25 mM CaCl2, 0.8 mM
MgCl2 in borate buffered saline, pH 7.2).
Isolation of viral RNA, reverse transcription, and PCR 
amplification (RT-PCR)
Viral RNA was isolated from the pelleted virus using the
QiAmp Viral RNA extraction mini kit (Qiagen). cDNA was
synthesized using the Omniscript RT kit (Qiagen) and an
oligodeoxynucleotide (5'-AGCAAAAGCAGG) that is com-
plementary to the 12 conserved nucleotides at the 3' end
of all influenza type A viral RNA segments. To amplify the
N2 NA fragment a pair of N2 NA specific primers were
used: 5'-GGGTCGACGCGTTTGAGCAAAAGCAGGAGT-
GAAAAT, complementary to nucleotides 1–21 at the 3'
end of viral RNA (bolded) preceded by a T3 promoter
sequence, and 5'-CGGAATTCATTAACCCTCACTAAAAG-
TAGAAACAAGGAG for the 5' end. The PCR conditions
were 94° for 5 min, then 5 cycles of: 94° for 1 min, anneal
at 32° for 1 min, extend at 72° for 2 min, followed by 25
cycles at higher temperature for specific binding of NA
primers (94° 1 min, anneal at 68° 1 min, synthesis at 72°
for 2 min and finally 72° for 7 min). To amplify all the 8
segments of influenza virus we used a pair of universal
primers, containing the 12 and 13 nucleotides comple-
mentary to the 3' and 5' terminal sequences of all 8 RNA
segments, attached to T7 promoter sequences for addi-
tional length. The primers were 5'-AATACGACTCAC-
TATAAGCAAAAGCAGG, complementary to the 3' end of
viral RNA and 5'-CGGAATTCAATACGACTCACTATAAG-
TAGAAACAAGG for the 5' end. The PCR conditions were
94° for 20 sec, anneal at 30° for 30 sec, extend at 72° for
5 min for 3 cycles followed by 30 cycles of 94° 20 sec,
anneal at 55° for 30 sec, extend at 72° for 15 min, and
finally 72° 7 min. The PCR products were separated by
electrophoresis on a 1% agarose gel and extracted using
the QiA Quick Gel Extraction kit (Qiagen). The purified
RT-PCR products were then sequenced in the Oklahoma
Medical Research Foundation DNA Sequencing Facility
using an ABI 3730 Capillary Sequencer with the NA spe-
cific primers for NA or universal primers for the 8 seg-
ments.
Hemagglutination and neuraminidase assays
Hemagglutinin titrations were done in 96 well plates
using 50 μl of serial dilutions of virus harvested from
MDCK cells, and adding 50 μl of 0.8% human red blood
cells. The plate was kept at 4°C and agglutination was
read at 90 min. Neuraminidase assays were done by fluo-
rescence using 4-methylumbelliferylα-N-acetyl-
neuraminic acid as substrate [31].
NA/HA ratios and tissue culture infectious units (TCIU)
To relate the NA activity to virus amount we used a ratio
of NA to HA. For NA, this was the fluorescence reading
generated by 5 μl virus-containing medium in 15 min
divided by the log2 of the HA titer of 50 μl of virus. This
arbitrary scale allowed comparison with the log(TCIU).
One TCIU was estimated as the geometric mean of the last
well showing infection in the 10-fold dilution series and
the next well. The assays were done immediately after har-
vesting the virus in MDCK supernatants to minimize any
instability in either HA or NA.
Virus growth in the presence of oseltamivir carboxylate
Viruses as serial 10-fold dilutions were used to infect
MDCK cells in the absence or presence of 10 μM to 0.001
μM oseltamivir added to the infection medium. After 3
days incubation at 37°C the cytopathic effect (cpe) was
estimated by eye and the HA titer was determined.
Cloning of deleted NA fragments of A/Oklahoma/309/06
We ligated the gel band at about 0.7 kb into pBluescript
IIKS+ digested with EcoRV and transformed it into One-
shot Top10 competent cells (Invitrogen). Three clones
were sequenced using primers T7 Promoter 5' TAATAC-
GACTCACTATAGGG complementary to the 3' end and
M13 5' AACAGCTATGACCAT for the 5' end, as well as
M13 5' GTTTTCCCAGTCACGAC complementary to 3'
end and M13 5' CAGGAAACAGCTATGAC for the 5' end.
Glycan Array analysis
Viruses were purified by 5–20% sucrose gradient centrifu-
gation and the purification checked by SDS gel electro-
phoresis. Labeling with Alexa-488 succinimidyl ester
(Molecular Probes) was monitored by HA titration and a
level chosen that did not result in reduction of HA titer;
for these viruses 0.005 μg Alexa per HAU. The reaction
conditions were as previously described [9]. After dialysis
the samples contained about 50 log2HAU per ml and
about 1 mg/ml viral protein. The Glycan Arrays printed on
glass slides were run by Core H of the Consortium for
Functional Glycomics. Alexa-labeled viruses were diluted
empirically and the slides incubated for 1 hour at pH 7,
4°C then washed and fluorescence measured using the
standard buffers and procedures of Core H [32]. Increas-
ing concentrations of virus were applied to the same slide
so approximate binding curves could be plotted for each
glycan.
RNA secondary structure analysis
The program mFold [10,11] was used to probe for possi-
ble secondary structures in RNA segment 6. We compared
the results using the default parameters and with the fol-
lowing changes: Percent suboptimality 10 (default 5),
Maximum interior/bulge loop size and maximum asym-
metry of bulge/loop both 10 (default 30).Virology Journal 2009, 6:22 http://www.virologyj.com/content/6/1/22
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